Novel Technologies News for June 2016

Novel Technologies News Archive

Owlstone Medical closes $7M (£4.9M) investment to commercialize disease breathalyzer Owlstone Medical closes $7M (£4.9M) investment to commercialize disease breathalyzer

Investment will fund ongoing clinical trials in lung and colon cancer screening

Welsh and Syrian scientists use date seeds to conquer toxins Welsh and Syrian scientists use date seeds to conquer toxins

Some of the most deadly environmental toxins, including dioxins, could soon be a thing of the past – thanks to the joint efforts of a Welsh scientist and partners in Syria and France.

Bubbly drinks inspire more effective cancer treatment Bubbly drinks inspire more effective cancer treatment

CANCER RESEARCH UK scientists are developing a bubbly drink packed with oxygen microbubbles to make treatments more potent for hard to treat tumours like pancreatic cancer.

Genome engineering of quantifiable protein tags: Western blot on the way down? Genome engineering of quantifiable protein tags: Western blot on the way down?

Cell biologists’ most notorious approach to detect and semi-quantify proteins, western blotting, could well be on its way down. Professor Sven Eyckerman (VIB/UGent) and colleagues developed a set of universal protein tags that warrant protein quantification via targeted proteomics techniques. The development and applications of these new tags - named Proteotypic peptides for Quantification by SRM (PQS) - are described in the online, open access journal Scientific Reports.